More
    Guided Solutions - Connecting Talent With Innovation/div>

    Know Labs Receives IRB Approval to Begin Internal Clinical Trial of Non-Invasive Glucose Monitoring Technology Bio-RFID™

    Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced it has received approval from an independent Institutional Review Board...

    Implanting standalone expandable cages following anterior cervical corpectomy and fusion is a safe and effective procedure

    The use of a standalone expandable cage in the cervical spine after one or two-level anterior cervical corpectomy and fusion (ACCF) without additional posterior...

    Royal Philips rolls out at-home ECG system for decentralized clinical trials

    The med tech company pitches this tool as a way to cut down on clinical trial attrition rates. Med tech giant Royal Philips is rolling...

    Exact Sciences posts early positive data from its next-generation Cologuard home screening test

    Exact Sciences presented new data for the second generation of its at-home Cologuard colorectal cancer test, which aims to improve upon its accuracy and...

    Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex® Scoring Balloon

    Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery...

    University of Cambridge Begins COVID-19 Clinical Trial Using PharmaJet’s Needle-free System

    PharmaJet®, the maker of innovative, needle-free injection technology, announced that its Needle-free Injection System (NFIS) will be used in a clinical trial to deliver...

    First patient implanted in integrated spinal fusion and DRG neuromodulation proof-of-concept study

    SynerFuse has announced the first implantation in the company’s proof-of-concept study, which will evaluate the safety and tolerability of simultaneously implanting spinal fusion hardware and...

    Robocath concludes first European clinical study to demonstrate safety and efficacy of robotic coronary angioplasty performed with R-One

    Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, announces today that it has concluded its...

    Movano Completes Blood Pressure Study with 110 Participants

    The Company plans to execute its second glucose clinical study in the first quarter of 2022  Movano Inc., a health technology company designing devices that...

    Latest articles